Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. 

Pharmaceutical

Immatics

Harpreet Singh

Lauren Schroeder

Mamta Kalra

Tamara Louw

Zoe Coughlin

Norbert Hilf

Jason Braun

Nina Möker

Evelyn Roth-Geissler

Kerry Sieger

Ali Mohamed

Claudia Blattner

Miriam Meyer

Steffen Walter

Carsten Reinhardt

Toni Weinschenk

Cedrik Britten

Rainer Kramer

Dominik Maurer

Michael Mølhøj

Edward Sturchio

Arnd Christ

Vice Presidents

Leadership Team

Leadership Tübingen

Management and Executive Operations

Leadership Houston

Clinical and Program Management

Scientific Advisory Team

Leadership Munich

Teams at Immatics